BD, Techcyte collab on AI-based cervical cytology

The digital cervical cytology system used in the partnership. [Image courtesy of BD]BD (NYSE: BDX) + announced today that it partnered with Techcyte on AI-based guidance for cytologists and pathologists.

The strategic collaboration aims to offer an AI algorithm to guide cytologists and pathologists to efficiently and effectively identify evidence of cervical cancer and precancer using whole-slide imaging.

Franklin Lakes, New Jersey-based BD said in a news release that the agreement allows it to deliver a complete solution to reduce the potential for human error and enable greater throughput. This helps labs achieve results with greater standardization, reproducibility and efficiency from a Pap test.

Traditional Pap tests take a sample from a patient and place it on a glass slide evaluated using a microscope. A digital cervical cytology system enables the scanning of the samples. Then comes a review on a computer mo…

Read more
  • 0